New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs
The DOI matches its Crossref record; 127 of the 128 references it cites were found in a registry or an index.
Abstract
Poly(ADP-ribose) polymerases (PARPs) are enzymes that transfer ADP-ribose groups to target proteins and thereby affect various nuclear and cytoplasmic processes. The activity of PARP family members, such as PARP1 and PARP2, is tied to cellular signalling pathways, and through poly(ADP-ribosyl)ation (PARylation) they ultimately promote changes in gene expression, RNA and protein abundance, and the location and activity of proteins that mediate signalling responses. PARPs act in a complex response network that is driven by the cellular, molecular and chemical biology of poly(ADP-ribose) (PAR). This PAR-dependent response network is crucial for a broad array of physiological and pathological responses and thus is a good target for chemical therapeutics for several diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Activated PARP1 will consume NAD+, generating PAR through a process called PARylation82.”
From Mitochondrial and metabolic dysfunction in ageing and age-related diseases (2022) · cites this paper as [82]
Citations
Cites
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
Fong, P. C., Boss, D. S., Yap, T. A., Tutt, A., Wu, P., Mergui-Roelvink, M., Mortimer, P., Swaisland, H., Lau, A., O'Connor, M. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900212 · Cited by 3,634
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Huang, S.-M. A., Mishina, Y. M., Liu, S., Cheung, A., Stegmeier, F., Michaud, G. A., Charlat, O., Wiellette, E., Zhang, Y., Wiessner, S., et al. (2009) · Nature · doi:10.1038/nature08356 · Cited by 2,037
Poly(ADP-ribose): novel functions for an old molecule
Schreiber, V., Dantzer, F., Ame, J.-C., & de Murcia, G. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1963 · Cited by 1,915
Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing Factor
Yu, S.-W., Wang, H., Poitras, M. F., Coombs, C., Bowers, W. J., Federoff, H. J., Poirier, G. G., Dawson, T. M., & Dawson, V. L. (2002) · Science · doi:10.1126/science.1072221 · Cited by 1,826
Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions
d'AMOURS, D., DESNOYERS, S., d'SILVA, I., & POIRIER, G. G. (1999) · Biochemical Journal · doi:10.1042/bj3420249 · Cited by 1,815
PARP inhibition: PARP1 and beyond
Rouleau, M., Patel, A., Hendzel, M. J., Kaufmann, S. H., & Poirier, G. G. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2812 · Cited by 1,298
Gelmon, K. A., Tischkowitz, M., Mackay, H., Swenerton, K., Robidoux, A., Tonkin, K., Hirte, H., Huntsman, D., Clemons, M., Gilks, B., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70214-5 · Cited by 1,117
Tankyrase, a Poly(ADP-Ribose) Polymerase at Human Telomeres
Smith, S., Giriat, I., Schmitt, A., & de Lange, T. (1998) · Science · doi:10.1126/science.282.5393.1484 · Cited by 1,012
Cited by
Items 301–400 of 1,000
Martello, R., Mangerich, A., Sass, S., Dedon, P. C., & Bürkle, A. (2013) · ACS Chemical Biology · doi:10.1021/cb400170b · Cited by 65
“PARylation occurs in a covalent manner by modifying specific amino acids or non-covalently via distinct PAR binding motifs (1, 2, 4, 6).”
BackgroundInfluentialSingle cell resolution in vivo imaging of DNA damage following PARP inhibition
Yang, K. S., Kohler, R. H., Landon, M., Giedt, R., & Weissleder, R. (2015) · Scientific Reports · doi:10.1038/srep10129 · Cited by 63
“These bulky, negatively charged PAR polymers affect numerous cellular processes, most notably by changing the localization and activity of signaling proteins 3–5 .”
BackgroundMiyazaki, T., Kim, Y.-S., Yoon, J., Wang, H., Suzuki, T., & Morse, H. C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.547331 · Cited by 63
“Although PARP1 is involved in many aspects of the cellular response to DNA damage, it plays a key role in BER of ssDNA break (19, 20).”
BackgroundA role of intracellular mono‐ ADP ‐ribosylation in cancer biology
Scarpa, E. S., Fabrizio, G., & Girolamo, M. D. (2013) · FEBS Journal · doi:10.1111/febs.12290 · Cited by 63
In vivo vizualisation of mono-ADP-ribosylation by dPARP16 upon amino-acid starvation
Aguilera-Gomez, A., van Oorschot, M. M., Veenendaal, T., & Rabouille, C. (2016) · eLife · doi:10.7554/elife.21475 · Cited by 61
“We show that dPARP16 catalytic activity is necessary and sufficient for both amino-acid starvation induced mono-ADP-ribosylation and subsequent Sec body formation and cell survival.”
BackgroundStructure of a (3+1) hybrid G-quadruplex in the PARP1 promoter
Sengar, A., Vandana, J. J., Chambers, V. S., Antonio, M. D., Winnerdy, F. R., Balasubramanian, S., & Phan, A. T. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1179 · Cited by 64
“PARP1 binds to DNA breaks and recruits DNA repair proteins by catalyzing the formation of poly (ADP-ribose) scaffolds (1,2).”
BackgroundBasse, A. L., Agerholm, M., Farup, J., Dalbram, E., Nielsen, J., Ørtenblad, N., Altıntaş, A., Ehrlich, A. M., Krag, T., Bruzzone, S., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101271 · Cited by 62
“However, it is also a crucial co-substrate for several NADþ degrading enzymes, such as sirtuins [1], Poly (ADPribose) Polymerases (PARPs) [2,3], and CD38, with ADP-ribosyl cyclase/NADþ-ase activity [4].”
BackgroundPARP inhibitors in gastric cancer: beacon of hope
Wang, Y., Zheng, K., Huang, Y., Xiong, H., Su, J., Chen, R., & Zou, Y. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02005-6 · Cited by 66
“have distinct structural domains, activities, subcellular localizations, and functions [22, 23].”
BackgroundCrosstalk between protein post-translational modifications and phase separation
Liu, Y., Feng, W., Wang, Y., & Wu, B. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01380-1 · Cited by 69
“This process is primarily catalyzed by a family of enzymes called Poly(ADP-ribose) polymerase (PARP), with PARP1 being the most well-known [125, 126].”
BackgroundHerzog, N., Hartkamp, J., Verheugd, P., Treude, F., Forst, A. H., Feijs, K. L. H., Lippok, B. E., Kremmer, E., Kleine, H. O., & Lüscher, B. (2013) · FEBS Journal · doi:10.1111/febs.12124 · Cited by 60
Medina, C. A., Reyes, P. A., Trujillo, C., Gonzalez, J. L., Bejarano, D. A., Montenegro, N., Jacobs, J. M., Joe, A., Restrepo, S., Alfano, J. R., et al. (2017) · Molecular Plant Pathology · doi:10.1111/mpp.12545 · Cited by 60
“The PARP catalytic domain binds NAD1 and shares homology with mono-ADP ribosylating toxins, such as exotoxinA and diphtheria toxin (Cherkis et al., 2012; Gibson and Kraus, 2012).”
BackgroundChen, J.-K., Lin, W.-L., Chen, Z., & Liu, H. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1713912115 · Cited by 70
“Since PAR polymers are highly negatively charged (12), PARylation of CIRBP may weaken its interaction with RNA.”
BackgroundLiu, Q., Gheorghiu, L., Drumm, M. R., Clayman, R. H., Eidelman, A., Wszolek, M. F., Olumi, A. F., Feldman, A. S., Wang, M., Marcar, L., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0130-6 · Cited by 67
“(PARP) family of nuclear and cytoplasmic proteins is involved in a multitude of cellular functions [1].”
Wang, G., Huang, X., Li, Y., Guo, K., Ning, P., & Zhang, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079757 · Cited by 67
“PARP-1 is the most abundant member of PARP family consisting of 17 enzymes which share a highly conserved PARP signature motif in the catalytic domain [13,14].”
BackgroundMacroD1 Is a Promiscuous ADP-Ribosyl Hydrolase Localized to Mitochondria
Agnew, T., Munnur, D., Crawford, K., Palazzo, L., Mikoč, A., & Ahel, I. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00020 · Cited by 60
“ADP-ribosylation is a chemical modification and is involved in the regulation of a number of processes including stress response, transcription, chromatin structure, DNA damage repair, cell division and apoptosis (Gibson and Kraus, 2012; Barkauskaite et al., 2015; Gupte et al., 2017; Palazzo et al., 2017).”
BackgroundADP-ribosylation: from molecular mechanisms to human disease
Hoch, N. C., & Polo, L. M. (2020) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2019-0075 · Cited by 59
“recognized as a central posttranslational modification in a range of cellular processes, such as DNA damage signalling and repair, transcription, Wnt signalling and programmed cell death (Gibson and Kraus, 2012; Virag, 2013; DaRosa et al., 2015; Kraus, 2015).”
BackgroundAbraham, R., McPherson, R. L., Dasovich, M., Badiee, M., Leung, A. K. L., & Griffin, D. E. (2020) · mBio · doi:10.1128/mbio.03253-19 · Cited by 59
Zhang, K., Yang, X., Zhao, Q., Li, Z., Fu, F., Zhang, H., Zheng, M., & Zhang, S. (2020) · Stem Cells International · doi:10.1155/2020/8892300 · Cited by 67
Synthesis and Macrodomain Binding of Mono‐ADP‐Ribosylated Peptides
Kistemaker, H. A. V., Nardozza, A. P., Overkleeft, H. S., van der Marel, G. A., Ladurner, A. G., & Filippov, D. V. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201604058 · Cited by 60
Synthesis of Well‐Defined Adenosine Diphosphate Ribose Oligomers
Kistemaker, H. A. V., Lameijer, L. N., Meeuwenoord, N. J., Overkleeft, H. S., van der Marel, G. A., & Filippov, D. V. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201412283 · Cited by 58
Mitotic functions of poly(ADP-ribose) polymerases
Slade, D. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.03.028 · Cited by 59
Szebeni, A., Szebeni, K., DiPeri, T. P., Johnson, L. A., Stockmeier, C. A., Crawford, J. D., Chandley, M. J., Hernandez, L. J., Burgess, K. C., Brown, R. W., et al. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw114 · Cited by 57
“One of the fastest cellular responses to oxidative damage of DNA is poly(ADP-ribosyl)ation, a posttranslational modification of nuclear proteins, catalyzed by the nuclear enzyme poly(ADP)-ribose polymerase-1 (PARP1) (Gibson and Kraus, 2012).”
BackgroundFactors Regulating the Activity of LINE1 Retrotransposons
Protasova, M., Андреева, Т. В., & Rogaev, E. I. (2021) · Genes · doi:10.3390/genes12101562 · Cited by 69
“For the classical mechanism of retrotransposition, host proteins involved in DNA repair and replication are necessary [34,39,40].”
BackgroundPARP inhibitors trap PARP2 and alter the mode of recruitment of PARP2 at DNA damage sites
Lin, X., Jiang, W., Rudolph, J., Lee, B. J., Luger, K., & Zha, S. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac188 · Cited by 57
“PARP1 and PARP2 are DNA damage activated poly-ADP-ribose polymerases (PARPs), which catalyze the transfer of the ADP-ribose unit from the nicotinamide adenine dinucleotide (NAD + ) to target proteins, including themselves and histones (1).”
Wang, Y., Rösner, D., Grzywa, M., & Marx, A. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201404431 · Cited by 57
MacroH2A – An epigenetic regulator of cancer
Cantariño, N., Douet, J., & Buschbeck, M. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.03.022 · Cited by 61
Autophagy requires poly(adp-ribosyl)ation-dependent AMPK nuclear export
Rodríguez-Vargas, J. M., Rodríguez, M. I., Majuelos‐Melguizo, J., García-Díaz, Á., González-Flores, A., López‐Rivas, A., Virág, L., Illuzzi, G., Schreiber, V., Dantzer, F., et al. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.80 · Cited by 58
“member of the PARP protein family accounting for around 90% of cellular PARylation activity following different stimuli.(8,9) Recent studies have demonstrated its involvement in the regulation of DNA damage- or starvation-induced autophagy.”
BackgroundThe Leloir Pathway of Galactose Metabolism – A Novel Therapeutic Target for Hepatocellular Carcinoma
Tang, M., ETOKIDEM, E., & Lai, K. (2016) · Anticancer Research · doi:10.21873/anticanres.11221 · Cited by 57
Aguilera-Gomez, A., & Rabouille, C. (2017) · Developmental Biology · doi:10.1016/j.ydbio.2017.03.029 · Cited by 59
“(consisting in the addition of two or more ADP-ribose units to a protein substrate by ADP-ribosyltransferases (PARPs) (Gibson and Kraus, 2012; Hottiger et al., 2010)) triggers events leading to liquid-liquid phase separation (Protter and Parker, 2016).”
BackgroundInfluentialDoes eating less make you live longer and better? An update on calorie restriction
Picca, A., Pesce, V., & Lezza, A. M. S. (2017) · Clinical Interventions in Aging · doi:10.2147/cia.s126458 · Cited by 53
Synthetic α- and β-Ser-ADP-ribosylated Peptides Reveal α-Ser-ADPr as the Native Epimer
Voorneveld, J., Rack, J. G. M., Ahel, I., Overkleeft, H. S., van der Marel, G. A., & Filippov, D. V. (2018) · Organic Letters · doi:10.1021/acs.orglett.8b01742 · Cited by 57
ADP-Ribosylation: Activation, Recognition, and Removal
Li, N., & Chen, J. (2014) · Molecules and Cells · doi:10.14348/molcells.2014.2245 · Cited by 53
“PARP16 acts as a mono-ADP-ribosyltransferase and negatively regulates the protein level of karyopherin-β1 (Di Paola et al., 2012).”
BackgroundInfluentialMolecular Insights into Poly(ADP-ribose) Recognition and Processing
Žaja, R., Mikoč, A., Barkauskaite, E., & Ahel, I. (2012) · Biomolecules · doi:10.3390/biom3010001 · Cited by 61
Proteomics approaches to identify mono‐(ADP‐ribosyl)ated and poly(ADP‐ribosyl)ated proteins
Vivelo, C. A., & Leung, A. K. L. (2014) · PROTEOMICS · doi:10.1002/pmic.201400217 · Cited by 59
“Several protein domains that bind mono- and poly(ADPribose) have been identified, such as the WWE domain, PBZ (PAR-binding zinc finger (PBZ) domain, and PARbinding motif (Table 3; reviewed in [5, 6, 53]).”
BackgroundStereoselective Ribosylation of Amino Acids
Kistemaker, H. A. V., van Noort, G. J. V. D. H., Overkleeft, H. S., van der Marel, G. A., & Filippov, D. V. (2013) · Organic Letters · doi:10.1021/ol400929c · Cited by 55
The solvent side of proteinaceous membrane-less organelles in light of aqueous two-phase systems.
Zaslavsky, B., Ferreira, L. A., Darling, A., & Uversky, V. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.06.030 · Cited by 41
“Nuclear PMLOs include amyloid bodies (A-bodies), [127], Cajal bodies (CBs) [128], chromatin [129], cleavage bodies [130], DNA damage foci [131, 132], histone locus bodies (HLBs), [133], nuclear gems (Gemini of coiled of Cajal bodies) [134, 135], nuclear HSF1 (heat shock factor 1) granules [136], nuclear pores [137], n…”
BackgroundPoly(ADP-Ribose) Polymerases in Plants and Their Human Counterparts: Parallels and Peculiarities
Rissel, D., & Peiter, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071638 · Cited by 57
“Similar to PARP1 and PARP2, it is activated by DNA strand breaks [4] and it confers mono(ADP-ribosyl)ation activity [32] and functions in DNA DSB repair [66,67].”
BackgroundPoly(ADP‐ribosyl)ation of BRD7 by PARP1 confers resistance to DNA‐damaging chemotherapeutic agents
Hu, K., Wu, W., Li, Y., Lin, L., Chen, D., Yan, H., Xiao, X., Chen, H., Chen, Z., Zhang, Y., et al. (2019) · EMBO Reports · doi:10.15252/embr.201846166 · Cited by 57
“Olaparib is a widely used PARP1 inhibitor which effectively blocks PARP1 catalytic activity [45] A HeLa and MDA-MB-231 cells were transfected with either scrambled or RNF 146 siRNAs ( 48 h).”
The Multifactorial Role of PARP-1 in Tumor Microenvironment
Martí, J. M., Fernández‐Cortés, M., Serrano-Sáenz, S., Zamudio-Martínez, E., Delgado‐Bellido, D., García-Díaz, Á., & Oliver, F. J. (2020) · Cancers · doi:10.3390/cancers12030739 · Cited by 60
“Proteins that do not fit into any of the previous classifications [9]; PARP-4 (ARTD4), PARP-6 (ARTD17), PARP-8 (ARTD16), PARP-10 (ARTD10), PARP-11 (ARTD11) and PARP-16 (ARTD15).”
BackgroundZheng, C., Zhang, X., Liu, W., Лю, Б., Yang, H., Lin, Z., & Chen, G. (2013) · Advanced Materials · doi:10.1002/adma.201302064 · Cited by 54
Martínez‐Zamudio, R. I., & Ha, H. C. (2014) · Brain and Behavior · doi:10.1002/brb3.239 · Cited by 59
“Keywords ADP-ribosylation, nucleosome, inflammation, gene expression, cytokine Correspondence Ricardo Iván Martı́nez Zamudio, Institut Pasteur, Unité de Recherche Organisation Nucléaire et Oncogenése, Bat.”
BackgroundAnalysis of Chromatin ADP-Ribosylation at the Genome-wide Level and at Specific Loci by ADPr-ChAP
Bartolomei, G., Leutert, M., Manzo, M., Baubec, T., & Hottiger, M. O. (2016) · Molecular Cell · doi:10.1016/j.molcel.2015.12.025 · Cited by 54
“At the molecular level, ADP-ribosylation affects the function of themodified proteins or provides a scaffold for the recruitment of regulatory proteins (Gibson and Kraus, 2012; Izhar et al., 2015).”
BackgroundFu, K., Sun, X., Wier, E. M., Hodgson, A., Liu, Y., Sears, C. L., & Wan, F. (2016) · eLife · doi:10.7554/elife.15018 · Cited by 58
“Sam68 controls DNA damage-induced PARylation Beyond its indispensable role in DNA repair (Gibson and Kraus, 2012), emerging evidence demonstrates that PARP1-mediated PARylation is one of the most crucial post-translational modifications orchestrating DNA damage-initiated NF-kB signaling (Stilmann…”
BackgroundNAD+: A key metabolic regulator with great therapeutic potential
Sultani, G., Samsudeen, A., Osborne, B., & Turner, N. A. (2017) · Journal of Neuroendocrinology · doi:10.1111/jne.12508 · Cited by 61
Chen, X., Huan, X., Liu, Q., Wang, Y., He, Q., Tan, C., Chen, Y., Ding, J., Xu, Y., Miao, Z., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.01.018 · Cited by 54
To spread or not to spread—chromatin modifications in response to DNA damage
Altmeyer, M., & Lukas, J. (2013) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2012.11.001 · Cited by 59
Kristensen, D. G., Nielsen, J. E., Jørgensen, A., Skakkebæk, N. E., Meyts, E. R., & Almstrup, K. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.727 · Cited by 53
“In addition to its role in BER, PARP1 participates in regulating the activity of a wide range of proteins involved in epigenetic modulation (Quenet et al, 2009; Gibson and Kraus, 2012).”
BackgroundZhou, L., Huo, M., Qian, X., Ding, L., Yu, L., Feng, W., Cui, X., & Chen, Y. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00855-y · Cited by 56
“As a cleavage substrate for caspase, cleaved poly-ADP-ribose polymerase (c-PARP) is extensively involved in cellular responses to DNA damage and DNA metabolism [48].”
BackgroundMitochondrial dysfunction, UPRmt signaling, and targeted therapy in metastasis tumor
Keerthiga, R., Pei, D., & Fu, A. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00696-0 · Cited by 54
“Therefore, Sirt1 promotes the activation of the UPRmt [45].”
BackgroundMeza‐Sosa, K. F., Miao, R., Navarro, F., Zhang, Z., Zhang, Y., Hu, J. J., Hartford, C. C. R., Li, X. L., Pedraza‐Alva, G., Pérez‐Martínez, L., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.01.001 · Cited by 53
Lloret, A., & Beal, M. F. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02809-1 · Cited by 52
Patel, M. R., Bhatt, A., Steffen, J. D., Chergui, A., Murai, J., Pommier, Y. G., Pascal, J. M., Trombetta, L. D., Fronczek, F. R., & Talele, T. T. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5002502 · Cited by 56
Schlesiger, S., Buntz, A., Wang, Y., Zumbusch, A., & Marx, A. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201600464 · Cited by 52
Dong, X., Yang, L., & Wang, H. (2016) · Gynecological Endocrinology · doi:10.1080/09513590.2016.1266476 · Cited by 52
“crucial functions in multiple physiologic and pathologic processes [17].”
BackgroundPARP10 suppresses tumor metastasis through regulation of Aurora A activity
Zhao, Y., Hu, X., Wei, L., Song, D., Wang, J., You, L., Saiyin, H., Li, Z., Yu, W., Yu, L., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0168-5 · Cited by 52
“PARPs hydrolyze nicotinamide adenine dinucleotide (NAD) and transfer the ADP-ribose (ADPR) moiety to acceptor proteins, including itself [1, 2].”
BackgroundReading ADP-ribosylation signaling using chemical biology and interaction proteomics
Kliza, K. W., Liu, Q., Roosenboom, L. W. M., Jansen, P. W. T. C., Filippov, D. V., & Vermeulen, M. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.037 · Cited by 56
Hu, X., Zhang, J., Zhang, Y., Jiao, F., Wang, J., Chen, H., Ouyang, L., & Wang, Y. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.114094 · Cited by 53
Cho, C., Lin, M.-H., Chuang, C.-Y., & Hsu, C. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.700542 · Cited by 51
“Thus, macro domain-containing proteins and enzymes may play important roles in regulating various cellular processes (30).”
BackgroundRBM45 competes with HDAC1 for binding to FUS in response to DNA damage
Gong, J., Huang, M., Wang, F., Ma, X., Liu, H., Tu, Y., Xing, L., Zhu, X., Zheng, H., Fang, J., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1102 · Cited by 53
“It is reported that RNA and PAR chain share similar structures (38).”
Miyoshi, T., Makino, T., & Moran, J. V. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.07.018 · Cited by 55
“PARP activation at DNA breaks leads to the recruitment of DNA repair proteins (Gibson and Kraus, 2012).”
BackgroundMethodInfluentialLawarée, E., Jankevicius, G., Cooper, C., Ahel, I., Uphoff, S., & Tang, C. M. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.014 · Cited by 54
“In eukaryotes, protein ADP-ribosylation has been studied extensively and influences fundamental processes such as transcription, cell division, metabolism, and DNA repair (Barkauskaite et al., 2015; Gibson and Kraus, 2012; Perina et al., 2014).”
BackgroundKhoury-Haddad, H., Nadar‐Ponniah, P. T., Awwad, S. W., & Ayoub, N. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1014147 · Cited by 56
“This promotes the rapid recruitment of PAR-binding proteins to DNA damage sites, which is important for efficient damage repair.(63) We hypothesize therefore that KDM4D binds PAR moieties.”
BackgroundRoles of NAD+ in Acute and Chronic Kidney Diseases
Morevati, M., Fang, E. F., Mace, M. L., Kanbay, M., Gravesen, E., Nordholm, A., Egstrand, S., & Hornum, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010137 · Cited by 50
“PARP1 is the most investigated protein in this family and is often called the guardian of the genome [52,54].”
BackgroundTargeting the DNA Damage Response for Cancer Therapy
Wang, R., Sun, Y., Li, C., Xue, Y., & Ba, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115907 · Cited by 61
“[57].”
Regulation of E2F1-induced apoptosis by poly(ADP-ribosyl)ation
Kumari, A., Iwasaki, T., Pyndiah, S., Cassimere, E. K., Palani, C. D., & Sakamuro, D. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.146 · Cited by 55
“30) is a nuclear enzyme that acts as a molecular sensor, detecting single-stranded DNA lesions.(20,21) The enzyme also promotes the deconcentration of higherorder chromatin structures by modifying histone poly(ADPribosyl)ation.”
BackgroundSmall Molecule Microarray Based Discovery of PARP14 Inhibitors
Peng, B., Thorsell, A. G., Karlberg, T., Schuler, H., & Yao, S. Q. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201609655 · Cited by 50
A novel non-canonical PIP-box mediates PARG interaction with PCNA
Kaufmann, T., Grishkovskaya, I., Polyansky, A. A., Kostrhon, S., Kukolj, E., Olek, K., Herbert, S., Beltzung, E., Mechtler, K., Peterbauer, T., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx604 · Cited by 52
“Poly(ADP-ribosyl)ation regulates a variety of cellular processes by providing a rapid and transient modulation of protein-protein and protein-DNA interactions (1).”
BackgroundPoly(ADP-ribose) mediates asymmetric division of mouse oocyte
Xie, B., Zhang, L., Zhao, H., Bai, Q., Fan, Y., Zhu, X., Yu, Y., Li, R., Liang, X., Sun, Q., et al. (2018) · Cell Research · doi:10.1038/s41422-018-0009-7 · Cited by 53
Enabling drug discovery for the PARP protein family through the detection of mono-ADP-ribosylation
Lu, A. Z., Abo, R., Ren, Y., Gui, B., Mo, J.-R., Blackwell, D. J., Wigle, T. J., Keilhack, H., & Niepel, M. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.05.007 · Cited by 50
“Most notably, PARP1 synthesizes poly-ADP-ribose chains in the nucleus that serve as a scaffold for DNA repair for the recruitment of DNA repair proteins containing PAR-binding modules to sites of DNA damage [3].”
BackgroundRecent advancements in PARP inhibitors-based targeted cancer therapy
Zhou, P., Wang, J. L., Mishail, D., & Wang, C. (2020) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbaa030 · Cited by 52
Jiang, Y. X., Luo, L., Hu, T., Cui, Y., Sun, X., Gou, W., Hou, W., Li, Y., & Sun, T. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113898 · Cited by 50
Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules
Nizi, M. G., Maksimainen, M. M., Lehtiö, L., & Tabarrini, O. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00281 · Cited by 51
Towards small molecule inhibitors of mono-ADP-ribosyltransferases
Ekblad, T., Lindgren, A. E. G., Andersson, C. D., Caraballo, R., Thorsell, A. G., Karlberg, T., Spjut, S., Linusson, A., Schuler, H., & Elofsson, M. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.03.067 · Cited by 49
“Diphtheria toxin-like ADP-ribosyl transferases (ARTDs), better known as poly(ADP-ribose) polymerases (PARPs), use nicotinamide adenine dinucleotide (NADþ) as co-substrate to transfer ADP-ribose to their target proteins [1,2].”
BackgroundZhong, X., & Wright, J. F. (2013) · International Journal of Cell Biology · doi:10.1155/2013/273086 · Cited by 48
A Double-Edged Sword: The Two Faces of PARylation
Kang, M., Park, S., Park, S., Lee, H. G., & Park, J. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179826 · Cited by 51
“PARPs, PARP-1, PARP-2, PARP-5a, and PARP-5b induce poly PARylation during the DNA damage response (DDR) and DNA repair [11].”
BackgroundHähnel, P. S., Enders, B., Sasca, D., Roos, W. P., Kaina, B., Bullinger, L., Theobald, M., & Kindler, T. (2014) · Blood · doi:10.1182/blood-2013-01-477620 · Cited by 52
Zang, C., Eucker, J., Liu, H., Coordes, A., Lenarz, M., Possinger, K., & Scholz, C. W. (2013) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2013.806800 · Cited by 53
Ni, S.-Y., Zhong, X., Li, Z., Huang, D., Xu, W., Zhou, Y., Ou, C., & Chen, M. (2020) · Cardiovascular Toxicology · doi:10.1007/s12012-020-09571-9 · Cited by 49
Nuclear ADP-ribosylation drives IFNγ-dependent STAT1α enhancer formation in macrophages
Gupte, R., Nandu, T. S., & Kraus, W. L. (2021) · Nature Communications · doi:10.1038/s41467-021-24225-2 · Cited by 49
Self-citationKelleher, A. M., Setlem, R., Dantzer, F., DeMayo, F. J., Lydon, J. P., & Kraus, W. L. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2109252118 · Cited by 49
“PARPs 1 and 2, the predominant nuclear PARPs, catalyze the polymerization of linear or branched chains of ADPR, called poly(ADPR) or PAR (11, 13).”
BackgroundInfluentialSelf-citationMulti-therapies Based on PARP Inhibition: Potential Therapeutic Approaches for Cancer Treatment
Zhang, J., Gao, Y., Zhang, Z., Zhao, J., Jia, W., Xia, C., Wang, F., & Liu, T. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01352 · Cited by 49
PARP inhibitors combined with radiotherapy: are we ready?
Sun, C., Chu, A., Song, R., Liu, S., Chai, T., Wang, X., & Liu, Z. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1234973 · Cited by 52
Wang, Z., Qian, H., Yiu, S., Sun, J., & Zhu, G. (2013) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2013.10.017 · Cited by 47
Nuclear PARP1 expression and its prognostic significance in breast cancer patients
Mazzotta, A., Partipilo, G., Summa, S. D., Giotta, F., Simone, G., & Mangia, A. (2015) · Tumor Biology · doi:10.1007/s13277-015-4465-0 · Cited by 50
“PARPs control a wide array of biological processes, including DNA repair, transcriptional and cell cycle regulation, chromatin architecture, inflammation and cell death [4, 5].”
BackgroundVirus–Host Interactions and the ARTD/PARP Family of Enzymes
Kuny, C. V., & Sullivan, C. S. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005453 · Cited by 47
PARPing for balance in the homeostasis of poly(ADP-ribosyl)ation
Schuhwerk, H., Atteya, R., Siniuk, K., & Wang, Z. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.09.011 · Cited by 49
Novel insights into PARPs in gene expression: regulation of RNA metabolism
Ke, Y., Zhang, J., Lv, X., Zeng, X., & Ba, X. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03120-6 · Cited by 43
“Two members of this family (PARP9 and 13) appear to lack any enzymatic activity [9] (Table 1), and five PARPs (PARPs 7, 10, and 12–14) contain well-characterized RNA-binding domains, which are defined as RBPs [10].”
BackgroundVecoli, C., Borghini, A., & Andreassi, M. G. (2020) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2020.108309 · Cited by 49
Wang, Y., Zhou, P., Li, P., Yang, F., & Gao, X. (2020) · Bioengineered · doi:10.1080/21655979.2020.1761512 · Cited by 47
“PARP1 also functions in other cellular processes, including transcriptional regulation and cell cycles [16].”
BackgroundThe Antiviral Activities of Poly-ADP-Ribose Polymerases
Malgras, M., Garcia, M., Jousselin, C., Bodet, C., & Lévêque, N. (2021) · Viruses · doi:10.3390/v13040582 · Cited by 47
“ADPribosylation can drastically affect the functions of target proteins by modulating their enzymatic activity and by facilitating their ubiquitination, leading to their degradation [2].”
BackgroundLi, S., Zhang, Y., Wang, N., Guo, R., Liu, Q., Lv, C., Wang, J., Wang, L., & Yang, Q. (2018) · Cell Death and Disease · doi:10.1038/s41419-020-2408-1 · Cited by 50
Schoumacher, M., Hurov, K. E., Lehár, J., Yan-Neale, Y., Mishina, Y., Sonkin, D., Korn, J. M., Flemming, D., Jones, M. D., Antonakos, B., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0138-t · Cited by 44
“Poly(ADP-ribose) polymerases (PARPs) constitute a family of enzymes that utilize NAD+ to catalyze the addition of poly(ADP-ribose) chains to target proteins (1-3).”
BackgroundA Small‐Molecule Protein–Protein Interaction Inhibitor of PARP1 That Targets Its BRCT Domain
Na, Z., Peng, B., Ng, S., Pan, S., Lee, J., Shen, H., & Yao, S. Q. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201410678 · Cited by 51
Liu, F. W., & Tewari, K. S. (2016) · Current Treatment Options in Oncology · doi:10.1007/s11864-015-0378-9 · Cited by 50
Rane, J. K., Erb, H. H. H., Nappo, G., Mann, V. M., Simms, M. S., Collins, A. T., Visakorpi, T., & Maitland, N. J. (2016) · Oncotarget · doi:10.18632/oncotarget.10207 · Cited by 47
“To inhibit PARP activity, the non-speciic PARP activity inhibitor, nicotinamide and PARP1 endoribonuclease-prepared siRNA (esiRNA) were used [36].”
MethodSorensen, J. C., Petersen, A. C., Timpani, C. A., Campelj, D. G., Cook, J., Trewin, A. J., Stojanovska, V., Stewart, M., Hayes, A., & Rybalka, E. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00137 · Cited by 53
Targeting PARP and autophagy evoked synergistic lethality in hepatocellular carcinoma
Zai, W., Chen, W., Han, Y., Wu, Z., Fan, J., Zhang, X., Luan, J., Tang, S., Jin, X., Fu, X., et al. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz104 · Cited by 46
Identification of probe-quality degraders for Poly(ADP-ribose) polymerase-1 (PARP-1)
Zhang, Z., Chang, X., Zhang, C., Zeng, S., Liang, M., Ma, Z., Wang, Z., Huang, W., & Shen, Z. (2020) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2020.1804382 · Cited by 46
“oxoundecyl)-2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzamide (2).”
Sam68 Is Required for DNA Damage Responses via Regulating Poly(ADP-ribosyl)ation
Sun, X., Fu, K., Hodgson, A., Wier, E. M., Wen, M. G., Kamenyeva, O., Xia, X., Koo, L. Y., & Wan, F. (2016) · PLoS Biology · doi:10.1371/journal.pbio.1002543 · Cited by 46
TARG1 protects against toxic DNA ADP-ribosylation
Tromans‐Coia, C., Sanchi, A., Moeller, G. K., Timinszky, G., Lopes, M., & Ahel, I. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab771 · Cited by 46
“ADP-ribosylation is a dynamic modification involved in a vast array of cellular processes such as the DDR, chromatin remodeling, transcription and cell death (24,53,54).”
Metadata
- Authors
- Gibson, B. A., & Kraus, W. L.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Kraus, W. Lee
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2012-06-20
- Volume
- 13
- Issue
- 7
- Pages
- 411-424
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W1965006127
- Cited by
- 1,226
- References
- 128
- Citations by year
- 2026: 58 · 2025: 79 · 2024: 76 · 2023: 84 · 2022: 94 · 2021: 113 · 2020: 108 · 2019: 83 · 2018: 97 · 2017: 94 · 2016: 86 · 2015: 91 · 2014: 77 · 2013: 79 · 2012: 7
- FWCI
- 8.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
- Keywords
- poly(ADP-ribosyl)ation, poly(ADP-ribose), PARP1, PARP2, PARP family, protein modification, signal transduction, gene expression regulation, PARP inhibitors
- MeSH terms
- Animals, Catalysis, Cell Nucleus, Cherubism, Cytoplasm, Gene Expression Regulation, Humans, Models, Molecular, Poly Adenosine Diphosphate Ribose, Poly(ADP-ribose) Polymerases, Polymers, Protein Conformation, Protein Processing, Post-Translational, RNA, Signal Transduction, Protein Structure, Tertiary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.